Table 2.
Point estimates and 95% CI for patient mortality at 1-year and 3-months, as well as independent ambulatory function* at 3- and 6-months by New England Spinal Metastasis Score (NESMS).
| Outcome | Proportion (%) | 95% CI | p-value |
|---|---|---|---|
| 1-year Mortality | <0.001 | ||
| NESMS 0 | 93 | 78, 99 | - |
| NESMS 1 | 69 | 55, 82 | - |
| NESMS 2 | 45 | 34, 57 | - |
| NESMS 3 | 13 | 5, 27 | - |
| 3-month Mortality | <0.001 | ||
| NESMS 0 | 60 | 41, 77 | - |
| NESMS 1 | 41 | 27, 56 | - |
| NESMS 2 | 8 | 3, 16 | - |
| NESMS 3 | 4 | 1, 15 | - |
| 3-month Independent Ambulatory Function | <0.001 | ||
| NESMS 0 | 7 | 1,22 | - |
| NESMS 1 | 14 | 6,27 | - |
| NESMS 2 | 59 | 47, 70 | - |
| NESMS 3 | 67 | 51, 80 | - |
| 6-month Independent Ambulatory Function | <0.001 | ||
| NESMS 0 | 10 | 2, 27 | - |
| NESMS 1 | 12 | 5, 25 | - |
| NESMS 2 | 40 | 29, 51 | - |
| NESMS 3 | 53 | 38, 68 | - |
*-
Accounting for mortality as competing risk